Friday, July 03rd, 2009

Hot Topics : Unique “Payout Method” Instantly Credits Your Bank Account on the 3rd Friday of Every Month

Stay Away From Kohlberg Kravis Roberts IPO

Jul 30th, 2008 | By Bill Bonner | Category: Featured, Financial News

Bill Bonner in The Daily Reckoning says private equity firms are one of the biggest humbugs of modern capitalism.

They buy companies from public shareholders, make a few cosmetic changes, and sell them back at a higher price. And now the granddaddy of private equity, Kohlberg Kravis Roberts (KKR), will be selling its own shares on the NYSE.

If the likes of KKR could reliably add value to companies and beat the market, they wouldn’t need to raise capital on a public exchange, says Bill. That’s why KKR’s last public offering in Amsterdam has lost 57% in value since 2006…

We have chuckled about it before, but we come back to it today because the granddaddy of private equity - Kohlberg Kravis Roberts - is preparing to sell shares to the public on the NYSE.

The idea of private equity is that a group of smart, well-financed, slick operators can get the better of the chumps in the public markets. The idea is probably right, but it makes nonsense of the whole premise of modern market theory - that the markets always know more than any individual or group of players. If the markets put a price of $100 on a stock - that’s what it is worth, no more, no less; at least, that’s the theory.

But the private equity hustlers nevertheless go into the public market, buy a company at a price set by the market, clean it up, cut it up, and then sell it back to the market at a higher price.

Supposedly, the private equity boys have “added value” by nipping and tucking on the corporate body before selling it back to the yahoos. But what do the financiers know about running a company? How is it possible that they are able to take a company out of the control of the people who know it best - founders, CEOs, managers - and improve it?

And even if they were to get lucky with one, what makes these dilettantes think they can do it 160 times - which is the number of buyouts completed by KKR? We don’t recall the details, but we remember a study showing that private equity surgeons had added no net value to the companies they sliced up… and that share prices tended to sink after the initial return to the market.

And then you have to wonder about the chutzpah of it. Public shareholders were getting smacked both coming and going - once when they sold a company to KKR for too little… and again when they bought it back for too much.

And now cometh KKR into the public markets to smack the poor lumpeninvestoriat again. This time, KKR says, in effect: we’re smarter than you are…  but we’re going to let you buy our shares anyway. Of course, if KKR really were smarter, why would they want to cut the little guys in? If they could reliably add value and produce above-market gains they could raise all the capital they could possibly need. Of course…they can’t. And now, with the chumps wising up, it’s getting harder for private equity players to raise money.

Nor is this the first time KKR has sold shares to the public. The IHT reports:

“KKR Private Equity Investors had its debut on the Amsterdam bourse at $25 on May 3, 2006, when KKR sold 200 million shares of the unit, valuing it at $5 billion. The shares have fallen more than 57% since then, to close Friday at $10.50.”

Source: The Daily Reckoning


AdvertisementFDA results worth $195,600, overnight

It could become the bestselling pill in medical history...

On March 30 - there’ll be an announcement of FDA results for a new drug that many experts believe could make early investors $195,600, overnight, and potentially even more.

One analyst writes, “This is the kind of situation that can literally change your life.” Forbes says, “It could be a billion-dollar drug.”

Click here for details.



More on this topic (What's this?) Read more on Kohlberg Capital, Private Equity at Wikinvest
Tags: , ,

By Bill Bonner

Related Articles



About the Author

Bill BonnerBest-selling investment author Bill Bonner is the founder and president of Agora Publishing. Owner of both Fleet Street Publications and MoneyWeek magazine in the UK, he is also author of the free daily e-mail The Daily Reckoning and three best-selling books, Financial Reckoning Day: Surviving The Soft Depression of the 21st Century, Empire of Debt: The Rise of an Epic Financial Crisis and Mobs, Messiahs and Markets..

See All Posts by This Author



The Daily Reckoning offers a "uniquely refreshing" perspective on the global economy, investing and the ability to live well in uncertain times. You will learn what you can expect from today's markets and how to prosper in the face of uncertainty.

See All Posts from This Publication

Leave Comment